SCHEMBL3276994

SCHEMBL3276994

CCOC(=O)c1[nH]c2ccccc2c1CN(C)Cc1ccccc1

nearest known ligand 0.65

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HTR6 P50406 2/20 0.65
HTR1A P08908 1/20 0.65
DRD2 P14416 1/20 0.65
DRD4 P21917 1/20 0.65
HTR1D P28221 1/20 0.65
HTR1B P28222 1/20 0.65
HTR1F P30939 1/20 0.65
HTR7 P34969 1/20 0.65
DRD3 P35462 1/20 0.65
HSD17B10 Q99714 2/20 0.56
SMN1; SMN2 Q16637 1/20 0.56
TUBB4A P04350 2/20 0.56
TUBB P07437 2/20 0.56
TUBA3C P0DPH7 2/20 0.56
TUBA1B P68363 2/20 0.56
TUBA4A P68366 2/20 0.56
TUBB4B P68371 2/20 0.56
TUBB3 Q13509 2/20 0.56
TUBB2A Q13885 2/20 0.56
TUBB8 Q3ZCM7 2/20 0.56

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7671532 0.84 HTR6 (0.68) HTR6HTR1ADRD2DRD4HTR1D
SCHEMBL7381366 0.83 HTR6 (0.74) HTR6HTR1ADRD2DRD4HTR1D
SCHEMBL3029129 0.81 HTR6 (0.75) HTR6HTR1ADRD2DRD4HTR1D
SCHEMBL3195026 0.79 HTR6 (0.73) HTR6HTR1ADRD2DRD4HTR1D
SCHEMBL9686881 0.78 HTR6 (0.71) HTR6HTR1ADRD2DRD4HTR1D
SCHEMBL3033159 0.78 HTR6 (0.80) HTR6HTR1ADRD2DRD4HTR1D
SCHEMBL4573014 0.77 HTR6 (0.70) HTR6HTR1ADRD2DRD4HTR1D
SCHEMBL4266152 0.77 HTR6 (0.70) HTR6HTR1ADRD2DRD4HTR1D
SCHEMBL9094606 0.77 HTR6 (0.73) HTR6HTR1ADRD2DRD4HTR1D
SCHEMBL1486947 0.76 HTR6 (1.00) HTR6HTR1ADRD2DRD4HTR1D

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1966134-B1 NOVEL FUSED PYRROLE DERIVATIVES HOFFMANN LA ROCHE (CH) 2014-03-12 EP disclosed
US-7696240-B2 Fused pyrrole derivatives HOFFMANN-LA ROCHE INC. (US) 2010-04-13 US disclosed
EP-1966134-A1 NOVEL FUSED PYRROLE DERIVATIVES F.HOFFMANN-LA ROCHE AG (CH) 2008-09-10 EP disclosed
WO-2007068621-A1 NOVEL FUSED PYRROLE DERIVATIVES F. HOFFMANN-LA ROCHE AG (CH) 2007-06-21 WO disclosed
US-20070142452-A1 Fused pyrrole derivatives HOFFMANN-LA ROCHE INC. 2007-06-21 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070142452-A1 Fused pyrrole derivatives CMA1, PREP, CPA3 HTR6 2069/4885HTR1A 1069/4885DRD2 1472/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.